HASVADA LTD
Company number 14344586 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
HASVADA LTD - Analysis Report
Company Number: 14344586
Analysis Date: 2025-07-20 17:38 UTC
Financial Health Assessment of HASVADA LTD as at 30 September 2024
1. Financial Health Score: D
Explanation: HASVADA LTD shows significant financial distress signals, including persistent negative net assets and working capital deficits over the last three years. The company’s balance sheet reflects a weak financial position with liabilities exceeding assets. While the company remains active and compliant with filings, the financial "vital signs" point to symptoms of liquidity and solvency stress, requiring urgent attention.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 2,479 | Very low long-term asset base; minimal investment in durable resources. |
| Current Assets | 1,947 | Low short-term assets; limited cash or receivables to fund operations. |
| Current Liabilities | 11,367 | Significant short-term obligations; high immediate debt. |
| Net Current Assets | -9,420 | Working capital negative; company cannot cover short-term debts from current assets. |
| Net Assets (Shareholders’ Funds) | -6,841 | Negative equity; liabilities exceed total assets, implying insolvency risk. |
| Share Capital Not Paid | 100 | Minimal unpaid capital, not materially impacting financial health. |
| Average Employees | 0 | No staff employed, possibly indicating a non-operational or asset holding entity. |
Interpretation of Vital Signs:
- The company’s negative working capital (net current assets) is a critical symptom of financial distress, suggesting challenges in meeting short-term obligations without external support.
- The negative net assets (equity) indicate the company’s liabilities exceed its assets, a red flag analogous to a patient’s vital signs showing organ stress.
- Fixed assets have decreased from £4,259 in 2023 to £2,479 in 2024, indicating possible asset disposals or depreciation without reinvestment.
- The absence of employees suggests the company might not be actively operating or is in early stages without operational scale.
- The company remains current with statutory filings, which is a positive sign of administrative compliance but does not mitigate financial health concerns.
3. Diagnosis: Financial Condition Assessment
HASVADA LTD is currently experiencing symptoms of financial distress, characterized by:
- Persistent negative equity over three years, indicating ongoing losses or capital erosion.
- A negative working capital position signaling liquidity problems; the company lacks sufficient short-term resources to cover immediate debts.
- The decline in fixed assets may reflect shrinking operational capacity or asset sales to meet obligations.
- The company’s classification as a micro entity suggests it operates on a small scale, but the financial figures indicate it is currently not financially sustainable without intervention.
- The director, who is also the sole significant controller, may need to inject additional capital or restructure liabilities to stabilize the company.
This state is analogous to a patient with chronic symptoms requiring immediate care: while not yet in critical failure, without treatment, the prognosis worsens.
4. Prognosis
If current financial trends persist without corrective action, HASVADA LTD faces:
- Increased risk of insolvency or inability to meet creditor demands.
- Potential requirement for restructuring, refinancing, or capital injection.
- Possible impact on supplier and stakeholder confidence.
- Limited operational growth due to constrained resources.
However, with targeted financial management interventions, the company can potentially stabilize its position.
5. Recommendations: Path to Financial Wellness
To improve HASVADA LTD’s financial health, consider the following:
- Capital Injection: The sole shareholder may need to increase equity funding to eliminate negative net assets and improve working capital.
- Cost Control and Revenue Enhancement: If operational, review expenses and explore revenue-generating opportunities to restore profitability.
- Debt Restructuring: Negotiate with creditors to extend payment terms or reduce liabilities to ease short-term cash flow pressure.
- Asset Management: Evaluate fixed assets for potential sale or better utilization; reinvest wisely to support core activities.
- Cash Flow Monitoring: Establish rigorous cash flow forecasts to anticipate and manage liquidity needs proactively.
- Regular Financial Reviews: Implement monthly financial health checks to catch emerging symptoms early.
- Engage Professional Advice: Consider consulting insolvency practitioners or business turnaround specialists for tailored strategies.
Executive Summary
Sign in to generate a free AI analysis of this company — no password needed, just an email link.